您好, 歡迎來到化工儀器網(wǎng)！ 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
您好, 歡迎來到化工儀器網(wǎng)！ 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
提供商
上海起發(fā)實(shí)驗(yàn)試劑有限公司資料大小
381.8KB資料圖片
下載次數(shù)
0次資料類型
EXCEL 文檔
瀏覽次數(shù)
13次Virogen 生物技術(shù)公司是一家在生物科研和生物制藥領(lǐng)域具有重要影響力的企業(yè)。在業(yè)務(wù)方面，Virogen 專注于為研究和診斷市場(chǎng)提供各類抗體、抗原及相關(guān)實(shí)驗(yàn)室設(shè)備。其產(chǎn)品種類豐富，涵蓋多個(gè)研究領(lǐng)域。在傳染病研究方面，提供用于乙肝檢測(cè)的重組乙肝核心抗原，該抗原從大腸桿菌中純化獲得，可用于抗體捕獲，貨號(hào)未明確在文檔中特殊標(biāo)注；還有針對(duì)多種病毒的抗原和抗體產(chǎn)品，如新冠病毒相關(guān)的多個(gè)抗原產(chǎn)品，像冠狀病毒 19 膜 - 包膜抗原（貨號(hào)：00225 - V）、冠狀病毒 19 核衣殼蛋白（貨號(hào)：00221 - V）、冠狀病毒 19 刺突（C）抗原（貨號(hào)：00223 - V）等，為新冠病毒相關(guān)研究提供了有力工具。針對(duì)其他病毒，如流感病毒、單純皰疹病毒（HSV）等也有相應(yīng)的抗原產(chǎn)品，HSV（皰疹病毒）gG 重組抗原（貨號(hào)：1140 - V）。在細(xì)胞相關(guān)研究中，有單鏈抗 CD 系列抗體，像單鏈抗 CD20 抗體（貨號(hào)：1152 - V）、單鏈抗 CD16 重組抗體（貨號(hào)：1151 - V）、單鏈抗 CD3 重組抗體（貨號(hào)：1150 - V） ，可用于細(xì)胞免疫等研究方向。此外，公司還提供如抗半胱氨酸單克隆抗體（貨號(hào)：102 - A）、抗麥角硫因多克隆抗體（貨號(hào)：105 - A）、抗谷胱甘肽單克隆抗體（貨號(hào)：101 - A、101 - A - 250、101 - A - 500）等多種特色抗體產(chǎn)品，滿足不同科研需求。
除了標(biāo)準(zhǔn)產(chǎn)品銷售，Virogen 還具備定制服務(wù)能力，其專家團(tuán)隊(duì)能夠與客戶緊密合作，優(yōu)化蛋白質(zhì)純化方案，滿足客戶個(gè)性化的科研需求。在發(fā)展歷程中，Virogen 不斷拓展業(yè)務(wù)版圖，積極與各方開展合作。2025 年，公司與美國成長型投行 Lake Street Capital Markets 達(dá)成戰(zhàn)略合作，借助對(duì)方的資源和專業(yè)能力，開展私募融資，加速核心產(chǎn)品的臨床推進(jìn)和商業(yè)化布局。同時(shí)，Virogen 還與藥明生物合作，委托藥明生物為其創(chuàng)新藥物 VG712 提供生產(chǎn)相關(guān)服務(wù)，共同推動(dòng)藥物上市。這些合作充分展示了 Virogen 在產(chǎn)業(yè)協(xié)同發(fā)展方面的積極態(tài)度和強(qiáng)大實(shí)力，也為其未來在生物科研和生物制藥領(lǐng)域的持續(xù)發(fā)展奠定了堅(jiān)實(shí)基礎(chǔ)。
特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購買相應(yīng)產(chǎn)品的同時(shí)我司會(huì)收取一定量的運(yùn)輸費(fèi)用?。?！本次報(bào)價(jià)有效時(shí)間為2025年6月26日---2025年12月14日。
（*此為部分產(chǎn)品價(jià)格,完整價(jià)格請(qǐng)下載文件）
貨號(hào) | 品名 | 規(guī)格 | 價(jià)格 | 品牌 |
00211-V-1mg | HHV-4 recombinant p18 antigen Region: 1-119aa | 1mg/vial | 20000.00 | Virogen |
00212-V-1mg | HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa | 1mg/vial | 20000.00 | Virogen |
00213-V-1mg | HHV-4 recombinant EA antigen. Region: 306-390aa | 1mg/vial | 20000.00 | Virogen |
00167-V-1mg | HDV Ag recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00214-V-1mg | Tick-born encephalitis virus gE recombinant antigen | 1mg/vial | 20000.00 | Virogen |
01005-V-1mg | Chlamydia trachomatis PDP3-D, Full length recombinant | 1mg/vial | 20000.00 | Virogen |
01011-V-1mg | Chlamydia trachomatis MOMP Recombinant antigen with out transmembrane domain. | 1mg/vial | 20000.00 | Virogen |
00206-V-1mg | Toxoplasma gondii MIC 3 recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00207-V-1mg | Toxoplasma gondii P24 (GRA1) recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00208-V-1mg | Toxoplasma gondii P29 (GRA7) recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00209-V-1mg | Toxoplasma gondii P30 (SAG1) recombinant antigen | 1mg/vial | 20000.00 | Virogen |
00111-V-1mg | HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa | 1mg/vial | 20000.00 | Virogen |
00112-V-1mg | HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa | 1mg/vial | 20000.00 | Virogen |
00113-V-1mg | HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa | 1mg/vial | 20000.00 | Virogen |
00114-V-1mg | HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa | 1mg/vial | 20000.00 | Virogen |
00168-V-1mg | HIV-1 p17/24/gp120-gp41 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00169-V-1mg | HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | 1mg/vial | 20000.00 | Virogen |
00170-V-1mg | HIV-1 gp41 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00171-V-1mg | HIV-1 gp41 Long recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00172-V-1mg | HIV-1 p17-p24 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00173-V-1mg | HIV-2 gp32 recombinant antigen. . | 1mg/vial | 20000.00 | Virogen |
00174-V-1mg | HIV-1 p24 recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00175-V-1mg | HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. | 1mg/vial | 20000.00 | Virogen |
00176-V-1mg | HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. | 1mg/vial | 20000.00 | Virogen |
00177-V-1mg | HIV 1 p24 core recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00178-V-1mg | HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | 1mg/vial | 20000.00 | Virogen |
00179-V-1mg | HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. | 1mg/vial | 20000.00 | Virogen |
00110-V-1mg | HIV-1 tat recombinant antigen full length 15 kDa | 1mg/vial | 20000.00 | Virogen |
00180-V-1mg | HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. | 1mg/vial | 20000.00 | Virogen |
00198-V-1mg | HIV-1 reverse transcriptase recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00199-V-1mg | HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). | 1mg/vial | 20000.00 | Virogen |
00115-V-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa | 1mg/vial | 20000.00 | Virogen |
00115-V-B-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. | 1mg/vial | 20000.00 | Virogen |
00115-V-F-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. | 1mg/vial | 20000.00 | Virogen |
00115-V-R-1mg | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. | 1mg/vial | 20000.00 | Virogen |
00116-V-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. | 1mg/vial | 20000.00 | Virogen |
00116-V-B-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. | 1mg/vial | 20000.00 | Virogen |
00116-V-F-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. | 1mg/vial | 20000.00 | Virogen |
00116-V-R-1mg | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. | 1mg/vial | 20000.00 | Virogen |
00117-V-1mg | HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | 1mg/vial | 20000.00 | Virogen |
00150-V-1mg | HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a | 1mg/vial | 20000.00 | Virogen |
00151-V-1mg | HCV core 24 antigen. | 1mg/vial | 20000.00 | Virogen |
00152-V-1mg | HCV core recombinant antigen a.a.105-302 | 1mg/vial | 20000.00 | Virogen |
00153-V-1mg | HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a | 1mg/vial | 20000.00 | Virogen |
00154-V-1mg | HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 | 1mg/vial | 20000.00 | Virogen |
00155-V-1mg | HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. | 1mg/vial | 20000.00 | Virogen |
00156-V-1mg | HCV NS4 1916-1947aa recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00157-V-1mg | HCV NS5 2061-2302aa recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00158-V-1mg | HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. | 1mg/vial | 20000.00 | Virogen |
00120-V-1mg | HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa | 1mg/vial | 20000.00 | Virogen |
00121-V-1mg | HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa | 1mg/vial | 20000.00 | Virogen |
00122-V-1mg | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant | 1mg/vial | 20000.00 | Virogen |
00123-V-1mg | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity | 1mg/vial | 20000.00 | Virogen |
00124-V-1mg | HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant | 1mg/vial | 20000.00 | Virogen |
00131-V-1mg | HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. | 1mg/vial | 20000.00 | Virogen |
00132-V-1mg | HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. | 1mg/vial | 20000.00 | Virogen |
00133-V-1mg | HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. | 1mg/vial | 20000.00 | Virogen |
00141-V-1mg | T. Pallidum recombinant antigen p15 (full length) | 1mg/vial | 20000.00 | Virogen |
00142-V-1mg | T. Pallidum recombinant antigen p17 (full length) | 1mg/vial | 20000.00 | Virogen |
00143-V-1mg | T. Pallidum recombinant antigen p45 (full length) | 1mg/vial | 20000.00 | Virogen |
00144-V-1mg | T. Pallidum recombinant antigen TmpA (full length) | 1mg/vial | 20000.00 | Virogen |
00185-V-1mg | CMV Pp65 (UL83) recombinant antigen , full length | 1mg/vial | 20000.00 | Virogen |
00188-V-1mg | CMV Pp65 (UL83) recombinant antigen a.a. 297-510 | 1mg/vial | 20000.00 | Virogen |
00189-V-1mg | CMV Pp52 (UL44) recombinant antigen a.a. 271-428 | 1mg/vial | 20000.00 | Virogen |
00187-V-1mg | CMV gB-AD1 (UL55) recombinant antigen a.a. 549-645 | 1mg/vial | 20000.00 | Virogen |
00186-V-1mg | CMV Pp150 recombinant antigen a.a. 426-606 | 1mg/vial | 20000.00 | Virogen |
00159-V-1mg | HAV VP1-P2A recombinant antigen a.a. 722-830. | 1mg/vial | 20000.00 | Virogen |
00160-V-1mg | HAV VP4-VP2 recombinant antigen a.a. 55-164. | 1mg/vial | 20000.00 | Virogen |
00161-V-1mg | HAV P2C-P3A recombinant antigen a.a. 1492-1606. | 1mg/vial | 20000.00 | Virogen |
00162-V-1mg | HAV P3C recombinant antigen a.a. 1643-1743. | 1mg/vial | 20000.00 | Virogen |
00163-V-1mg | HAV VP3 recombinant antigen a.a. 304-415. | 1mg/vial | 20000.00 | Virogen |
00164-V-1mg | HAV VP1-P2A recombinant antigen a.a. 669-782. | 1mg/vial | 20000.00 | Virogen |
00165-V-1mg | HAV HAV P2C recombinant antigen a.a. 1121-1234. | 1mg/vial | 20000.00 | Virogen |
00166-V-1mg | HAV P2C-P3A recombinant antigen a.a. 1392-1521. | 1mg/vial | 20000.00 | Virogen |
00181-V-1mg | HSV-1 gD recombinant antigen a.a. 266-394. | 1mg/vial | 20000.00 | Virogen |
00182-V-1mg | HSV-2 gD recombinant antigen a.a. 266-394. | 1mg/vial | 20000.00 | Virogen |
00183-V-1mg | HSV-2 gD recombinant antigen a.a. 525-578. | 1mg/vial | 20000.00 | Virogen |
00184-V-1mg | HSV-1 gD recombinant antigen a.a. 84-175. | 1mg/vial | 20000.00 | Virogen |
1131-V-1mg | HSV-2 gB recombinant antigen | 1mg/vial | 20000.00 | Virogen |
1140-V-1mg | E. coli recombinant HSV II gG antigen. Immunodominant Region: a.a. 525-578 | 1mg/vial | 20000.00 | Virogen |
00203-V-1mg | HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. | 1mg/vial | 20000.00 | Virogen |
00204-V-1mg | HLTV-I p24 core recombinant antigen. | 1mg/vial | 20000.00 | Virogen |
00205-V-1mg | HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. | 1mg/vial | 20000.00 | Virogen |
00700-V-1mg | HTLV-1 gp21 recombinant protein | 1mg/vial | 20000.00 | Virogen |
00701-V-1mg | HTLV-1 gp46 recombinant protein | 1mg/vial | 20000.00 | Virogen |
00215-V-1mg | Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. | 1mg/vial | 20000.00 | Virogen |
00216-V-1mg | Rubella virus E2 recombinant antigen a.a. 31-105. | 1mg/vial | 20000.00 | Virogen |
00217-V-1mg | Rubella virus capsid (C) recombinant antigen a.a. 1-123. | 1mg/vial | 20000.00 | Virogen |
00191-V-1mg | SARS-Associated Coronavirus E recombinant antigen a.a. 1-76. | 1mg/vial | 20000.00 | Virogen |
00192-V-1mg | SARS-Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1-49. | 1mg/vial | 20000.00 | Virogen |
00193-V-1mg | SARS-Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340-390. | 1mg/vial | 20000.00 | Virogen |
00194-V-1mg | SARS-Associated Coronavirus M recombinant antigen a.a. 182-216. | 1mg/vial | 20000.00 | Virogen |
00195-V-1mg | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. | 1mg/vial | 20000.00 | Virogen |
00196-V-1mg | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. | 1mg/vial | 20000.00 | Virogen |
00197-V-1mg | SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. | 1mg/vial | 20000.00 | Virogen |
00200-V-1mg | VZV gE recombinant antigen a.a. 48-135. | 1mg/vial | 20000.00 | Virogen |
00201-V-1mg | VZV ORF9 recombinant antigen a.a. 6-28/76-100. | 1mg/vial | 20000.00 | Virogen |
00202-V-1mg | VZV ORF26 recombinant antigen a.a. 9-33/184-208. | 1mg/vial | 20000.00 | Virogen |
00401-V-1mg | West Nile Virus Envelope recombinant antigen-Immunodominant region | 1mg/vial | 20000.00 | Virogen |
00402-V-1mg | West Nile Virus Pre-M recombinant antigen-Immunodominant region | 1mg/vial | 20000.00 | Virogen |
00403-V-1mg | West Nile Virus Envelope full length recombinant antigen 42 kDa region | 1mg/vial | 20000.00 | Virogen |
00345-V-1mg | Zika Virus ENV -NS1 fusion antigen 54 kDa | 1mg/vial | 20000.00 | Virogen |
00346-V-1mg | Zika Virus NS1 antigen 34 kDa | 1mg/vial | 20000.00 | Virogen |
00347-V-1mg | H. pylori CogA antigen 34 kDa | 1mg/vial | 20000.00 | Virogen |
00321-V-1mg | Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 | 1mg/vial | 20000.00 | Virogen |
1170-V-1mg | Human Endogenous Retrovirus Envelope antigen 48 kDa | 1mg/vial | 20000.00 | Virogen |
3001-V-1mg | Prostatic pacid hosphatase - full length (human) | 1mg/vial | 20000.00 | Virogen |
3002-V-1mg | Ovine Prolactin | 1mg/vial | 20000.00 | Virogen |
00820-V-1mg | MPXV A29 (recombinant), partial., a.a. 1-110. pI/Mw: 6.44 / 13382.09 | 1mg/vial | 20000.00 | Virogen |
00821-V-1mg | MPXV A27 (recombinant), partial., a.a. 1-110. MW: ~14 kDa | 1mg/vial | 20000.00 | Virogen |
00900-V-1mg | Phospholipase A2 P00630 Bee Venom Recombinant Protein | 1mg/vial | 20000.00 | Virogen |
00901-V-1mg | Soy Bean p34 Recombinant protein | 1mg/vial | 20000.00 | Virogen |
900-V-1mg | Dermatophagoides farina Der F1 antigen (recombinant). Full length. Non enzymatically active. | 1mg/vial | 20000.00 | Virogen |
901-V-1mg | Dermatophagoides pteronyssinus Der P1 antigen . Full length. Non enzymatically active. | 1mg/vial | 20000.00 | Virogen |
012-A-1mg | anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
013-A-1mg | anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
014-A-1mg | anti-HIV-1 p17 IgG1 (monoclonal) Produced against a recombinant protein | 1mg/vial | 20000.00 | Virogen |
0114-A-1mg | anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
015-A-1mg | anti-HIV-1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
016-A-1mg | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
017-A-1mg | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
018-A-1mg | anti-HCV NS4 IgG2a (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
020-A-1mg | anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate | 1mg/vial | 20000.00 | Virogen |
021-A-1mg | anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. | 1mg/vial | 20000.00 | Virogen |
022-A-1mg | anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. | 1mg/vial | 20000.00 | Virogen |
023-A-1mg | anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. | 1mg/vial | 20000.00 | Virogen |
024-A-1mg | anti-HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. | 1mg/vial | 20000.00 | Virogen |
025-A-1mg | anti-Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus | 1mg/vial | 20000.00 | Virogen |
026-A-1mg | anti-Adenovirus C11 IgG2a (monoclonal) Produced against purified Ad7 virus | 1mg/vial | 20000.00 | Virogen |
027-A-1mg | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 1mg/vial | 20000.00 | Virogen |
028-A-1mg | anti-TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. | 1mg/vial | 20000.00 | Virogen |
030-A-1mg | anti-HBcAg core IgM (monoclonal) Produced against recombinant HBcAg core antigen. | 1mg/vial | 20000.00 | Virogen |
031-A-1mg | anti-HBsAg pre-surface IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 1mg/vial | 20000.00 | Virogen |
032-A-1mg | anti-HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 1mg/vial | 20000.00 | Virogen |
033-A-1mg | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 70 – 80 a.a. | 1mg/vial | 20000.00 | Virogen |
034-A-1mg | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 135-140 a.a. | 1mg/vial | 20000.00 | Virogen |
035-A-1mg | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope:141-154 a.a. | 1mg/vial | 20000.00 | Virogen |
036-A-1mg | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 1-10 a.a. | 1mg/vial | 20000.00 | Virogen |
037-A-1mg | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 138- 145 a.a. | 1mg/vial | 20000.00 | Virogen |
038-A-1mg | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 130-140 a.a. | 1mg/vial | 20000.00 | Virogen |
0116-A-1mg | anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 1mg/vial | 20000.00 | Virogen |
0117-A-1mg | anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 1mg/vial | 20000.00 | Virogen |
216-A-1mg | anti-HCV core IgG1 (monoclonal)Produced against recombinant antigen | 1mg/vial | 20000.00 | Virogen |
245-A-1mg | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 | 1mg/vial | 20000.00 | Virogen |
246-A-1mg | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen | 1mg/vial | 20000.00 | Virogen |
247-A-1mg | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 | 1mg/vial | 20000.00 | Virogen |
266-A-1mg | anti-HCV NS5b rabbit (polycnonal)Produced against a recombinant protein | 1mg/vial | 20000.00 | Virogen |
199-A-1mg | anti-HCV NS5a rabbit (polycnonal) Produced against a recombinant protein | 1mg/vial | 20000.00 | Virogen |
276-A-1mg | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 1mg/vial | 20000.00 | Virogen |
010-A-1mg | anti-Rabies G antigen monoclonal antibody. Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
111-A-1mg | anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
101-A-1mg | anti-Glutathione monoclonal antibody IgG1 | 1mg/vial | 20000.00 | Virogen |
102-A-1mg | anti-Cysteine monoclonal antibody IgG1 | 1mg/vial | 24000.00 | Virogen |
105-A-1mg | anti-Ergothioneine rabbit polyclonal antibody | 1mg/vial | 24000.00 | Virogen |
041-A-1mg | anti-Thyroxine monoclonal antibody IgG2a | 1mg/vial | 24000.00 | Virogen |
011-A-1mg | anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. | 1mg/vial | 20000.00 | Virogen |
019-A-1mg | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
029-A-1mg | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
039-A-1mg | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 1mg/vial | 20000.00 | Virogen |
049-A-1mg | anti-FAS IgM (monoclonal) | 1mg/vial | 20000.00 | Virogen |
059-A-1mg | anti-SLAM anti-CDw150 IgG2a (monoclonal) Produced against an activated B cell line. | 1mg/vial | 20000.00 | Virogen |
069-A-1mg | anti-CD37 IgG2b (monoclonal) Produced against a B cell line. | 1mg/vial | 20000.00 | Virogen |
079-A-1mg | anti-Nuclear Antigen (Proliferating Cells) IgM (monoclonal) Produced against a proliferating Harvey cell line. | 1mg/vial | 20000.00 | Virogen |
066-A-1mg | anti-p53, clone BP53-12 | 1mg/vial | 20000.00 | Virogen |
060-A-1mg | anti-CD3 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
061-A-1mg | anti-CD4 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
062-A-1mg | anti-CD8 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
063-A-1mg | anti-CD16 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
064-A-1mg | anti-CD20 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
065-A-1mg | anti-CD22 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
067-A-1mg | anti-CD45 RA IgG2 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
068-A-1mg | anti-CD54 IgG2b-k monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
071-A-1mg | anti-CD19 IgG1 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
089-A-1mg | anti-CD66e IgG1 monoclonal antibody | 1mg/vial | 20000.00 | Virogen |
501-A-1mg | anti-CD3 T-cell | 1mg/vial | 20000.00 | Virogen |
502-A-1mg | anti-CD4 T helper cells | 1mg/vial | 20000.00 | Virogen |
503-A-1mg | anti-CD5 All T-cells | 1mg/vial | 20000.00 | Virogen |
504-A -1mg | anti-CD7 All T-cells | 1mg/vial | 20000.00 | Virogen |
505-A -1mg | anti-CD8 T cytotoxic/supressor cells | 1mg/vial | 20000.00 | Virogen |
506-A -1mg | anti-CD10 Lymphoblasts | 1mg/vial | 20000.00 | Virogen |
507-A -1mg | anti-CD16 NK-cells, monocytes, granulocytes | 1mg/vial | 20000.00 | Virogen |
508-A -1mg | anti-CD18 Leucocytes | 1mg/vial | 20000.00 | Virogen |
509-A-1mg | anti-CD20 B-lymphocytes | 1mg/vial | 20000.00 | Virogen |
510-A-1mg | anti-CD22 B-lymphocytes | 1mg/vial | 20000.00 | Virogen |
511-A-1mg | anti-CD25 IL-2 receptor expressed on activated T and B cells | 1mg/vial | 20000.00 | Virogen |
512-A-1mg | anti-CD26 Activated T, B lymphocytes and macrophages | 1mg/vial | 20000.00 | Virogen |
513-A-1mg | anti-CD34 Hematopoietic precursor cells | 1mg/vial | 20000.00 | Virogen |
514-A-1mg | anti-CD38 Hematopoietic precursors, thymocytes, activated T-cells, plasma cells | 1mg/vial | 20000.00 | Virogen |
515-A-1mg | anti-CD45 Leukocytes | 1mg/vial | 20000.00 | Virogen |
516-A-1mg | anti-CD45 RA B-cells, T-cells, NK-cells | 1mg/vial | 20000.00 | Virogen |
517-A-1mg | anti-ICAM-3, Leukocytes | 1mg/vial | 20000.00 | Virogen |
518-A-1mg | anti-Transferrin receptor on activated T-B-, cells | 1mg/vial | 20000.00 | Virogen |
519-A-1mg | anti-FAS antigen | 1mg/vial | 20000.00 | Virogen |
520-A-1mg | anti-HLA-DR | 1mg/vial | 20000.00 | Virogen |
521-A-1mg | anti-HLA-ABC on all Leukocytes | 1mg/vial | 20000.00 | Virogen |
522-A-1mg | anti-IgM Heavy chain expressed on B cells | 1mg/vial | 20000.00 | Virogen |
523-A-1mg | anti-Cortical thymocytes | 1mg/vial | 20000.00 | Virogen |
131-A-1mg | anti-RhoD human antigen IgG1 | 1mg/vial | 20000.00 | Virogen |
132-A-1mg | anti-A1, A2 human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
133-A-1mg | anti-A1, A2, A3 human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
134-A-1mg | anti-B human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
135-A-1mg | anti-AB human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
136-A-1mg | anti-Rh(o)D human antigen IgM | 1mg/vial | 20000.00 | Virogen |
137-A-1mg | anti-Rh(o)D and Rh(o)Dii human Rhesus system antigen IgG1 | 1mg/vial | 20000.00 | Virogen |
138-A-1mg | anti-RhoC human Rhesus system antigen IgM | 1mg/vial | 20000.00 | Virogen |
139-A-1mg | anti-A1, A2 human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
140-A-1mg | anti-B human blood group antigen IgM | 1mg/vial | 20000.00 | Virogen |
141-A-1mg | anti-H n/ab human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
142-A-1mg | anti-H ab human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
143-A-1mg | anti-H inh human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
144-A-1mg | anti-M human blood antigen IgM | 1mg/vial | 20000.00 | Virogen |
145-A-1mg | anti-N human blood antigen Ig2b | 1mg/vial | 20000.00 | Virogen |
146-A-1mg | Antiglobulin (COOMBS) Rabbit polyclonal | 1mg/vial | 20000.00 | Virogen |
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供，信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé)，化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示：為規(guī)避購買風(fēng)險(xiǎn)，建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。
